Nan Fung Life Sciences is a global healthcare investment firm focusing on high-impact therapeutics to address unmet medical needs. The company invests across North America, Europe, and Greater China, targeting transformative healthcare companies and publicly traded life sciences entities. It leverages deep industry knowledge and a global presence to support innovation and growth in the life sciences ecosystem.
Recent Transactions involving Nan Fung Life Sciences
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Engrail Therapeutics Acquires NeuroCycle Therapeutics |
NeuroCycle Therapeutics |
Engrail Therapeutics |
Nan Fung Life Sciences |
Pharmaceutical Manufacturing |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →